Dr. Anne Wagner is a clinical psychologist and treatment development researcher based in Toronto, Canada. She is the founder of Remedy, a mental health innovation community, and Remedy Institute, Remedy’s home for research. She is the principal investigator of the pilot trial of Cognitive Processing Therapy (CPT) for PTSD + MDMA, and the randomized controlled trial of Cognitive Behavioral Conjoint Therapy (CBCT) for PTSD + MDMA. Anne collaborates on numerous projects with other researchers, spanning across the fields of psychedelics, trauma, couples therapy, HIV, and the experiences of women. She speaks to us today about how MDMA might be a part of relational healing.
Episode Highlights:
- Dr. Anne Wagner's personal journey and her experience of psychedelics in a therapeutic context
- Why psychedelics are considered "a non-specific amplifier of the unconscious"
- How MDMA might be a part of relational healing
- Why psychedelics are not a “one dose miracle cure”
- Why psychedelics are considered contextual
- Remedy Centre & Remedy Institute
For more information about Dr. Anne Wagner, please visit:
https://integration.maps.org/anne-wagner/
For more information Remedy Centre & Remedy Institute, please visit:
https://remedycentre.ca/
https://www.remedyinstitute.ca/
Contact Us
info@blumatterproject.com
https://blumatterproject.com/